Rockefeller Capital Management’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.4K Sell
963
-172
-15% -$2.52K ﹤0.01% 3847
2025
Q4
$15.1K Hold
1,135
﹤0.01% 3639
2025
Q3
$17.9K Buy
+1,135
New +$18.7K ﹤0.01% 3403
2022
Q4
Sell
-19
Closed 4008
2022
Q3
$0 Hold
19
﹤0.01% 4083
2022
Q2
$0 Sell
19
-345
-95% -$4.39K ﹤0.01% 4224
2022
Q1
$6K Buy
364
+313
+614% +$7.97K ﹤0.01% 3273
2021
Q4
$1K Hold
51
﹤0.01% 3645
2021
Q3
$1K Hold
51
﹤0.01% 3571
2021
Q2
$2K Buy
51
+19
+59% +$549 ﹤0.01% 3246
2021
Q1
$0 Hold
32
﹤0.01% 3305
2020
Q4
$1K Buy
+32
New +$984 ﹤0.01% 2723
2020
Q2
Sell
-400
Closed -$7K 2618
2020
Q1
$7K Sell
400
-51
-11% -$1.23K ﹤0.01% 1855
2019
Q4
$11K Buy
451
+51
+13% +$1.12K ﹤0.01% 1582
2019
Q3
$7K Hold
400
﹤0.01% 1528
2019
Q2
$9K Hold
400
﹤0.01% 1272
2019
Q1
$12K Buy
+400
New +$9.97K ﹤0.01% 1424

Other funds holding HCM

Rockefeller Capital Management's HCM Position: Q1 2026 in Review

Rockefeller Capital Management reduced its HUTCHMED (HCM) stake by 15% in Q1 2026, selling an estimated $2.52K and leaving 963 shares worth $14.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3847.

Rockefeller Capital Management first reported a position in HCM in Q1 2019 and has held it in 16 quarters since. The position peaked at $17.9K in Q3 2025. 54 funds tracked by Wall St. Rank hold HCM as of Q1 2026.

  • Rockefeller Capital Management held 963 shares of HUTCHMED worth $14.4K as of Q1 2026.
  • Rockefeller Capital Management sold 172 HUTCHMED shares in Q1 2026, an estimated $2.52K.
  • HUTCHMED made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #3847 holding.
  • Rockefeller Capital Management first reported a position in HUTCHMED in Q1 2019 and has held it in 16 quarters since.
  • Rockefeller Capital Management's HUTCHMED position peaked at $17.9K in Q3 2025.
  • 54 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.